| Application no. and date | 18771465.4 (espacenet) (Federated) (European Patent Register), 20180314 | | Patent/reg. no. and date | DK/EP 3600419, 20230809 | | Publication date | 20200205 | | Priority no. and date | US 201762473731 P, 20170320 | | EP pub. no. and date |
EP 3600419 20200205 | | Effective date | | | Applicant/owner | Vaccinex, Inc., 1895 Mt. Hope Avenue
Rochester, NY 14620, US | | Applicant ref. no. | 22135DK00 | | Inventor | ZAUDERER, Maurice, 44 Woodland Road
Pittsford, New York 14534, US,
EVANS, Elizabeth, 41 Main Street
Bloomfield, New York 14469, US,
SMITH, Ernest S., 67 Longton Place
West Henrietta, New York 14586, US | | Representative | Inspicos P/S, Strandvejen 60 , 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/4406 (2006.01) , A61K 31/7068 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT | | Int. application no. | US2018022414 | | Int. publication no. | WO2018175179 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
